Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Clinical trial NCT05047094 · RECRUITING

Trial details

NCT number: NCT05047094
Sponsor: Alpha Tau Medical LTD.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Skin Cancer Metastatic Head-and-neck Squamous-cell Carcinoma

Start date: 2021-11-02
Primary completion: 2026-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.